Skip to content

Bowel cancer is rising in people under 50. They are still being told they're too young.

What the data actually shows, why nobody yet knows the cause, and the referral rule that changed in 2023 without anyone noticing.

By Dr Parisah Hussain9 min read

Bowel cancer is rising sharply in people under 50 across most of the world, and nobody yet knows why. The risk tracks the year you were born, which points at something that changed in early life rather than anything you are doing now. The practical part: UK referral rules quietly changed in 2023, a FIT test is now recommended for an unexplained change in bowel habit in any adult with no waiting period, and the absolute risk is still low while the dismissal is real.

Leading, not rare

Here is a sentence that would have sounded absurd when I was at medical school: bowel cancer is now the leading cause of cancer death in American men under 50, and the second in American women of the same age, behind breast cancer. That is not a projection. It is the American Cancer Society's own statistics, reported by Siegel and colleagues in 2024.

US readers: bowel cancer is the same disease you know as colon cancer or colorectal cancer.

This is not an American oddity. In the UK, bowel cancer rates in the under 50s have risen by around 50% since the mid-1990s, while rates in older adults have been stable or falling.

A 2025 analysis in The Lancet Oncology by Sung and colleagues found early-onset bowel cancer rising in 27 of the 50 countries examined, and England was one of the four steepest climbs in the world. Wherever researchers look closely, the same picture: the disease we were taught belonged to later life has stopped respecting the boundary.

A birth-year effect

The strangest part is that the risk tracks the year you were born. Siegel and colleagues' landmark 2017 analysis in the Journal of the National Cancer Institute found that Americans born around 1990 face roughly double the risk of colon cancer, and quadruple the risk of rectal cancer, that people born in 1950 faced at the same age.

In the US, the share of bowel cancer diagnoses in people under 55 doubled from 11% in 1995 to 20% in 2019. Something changed for the generations born after about 1960, and it has followed them as they age.

I sit inside those birth years myself, and so do most of the people reading this. I find it genuinely strange to look at that graph and understand that it is not describing somebody else's generation. It is describing mine.

This rise is not an artefact of better detection. The age groups affected have mostly been below screening age the whole time, and late-stage diagnoses are rising too, which is the opposite of what you would see if screening were simply catching cancers earlier. In the US, 57% of new bowel cancers were advanced at diagnosis in 1995. That fell to 52% in the mid-2000s as screening spread, then climbed back to 60% by 2019.

Why? The honest answer

The honest answer is that nobody knows yet. As a doctor I find that an uncomfortable sentence to write, and you deserve it anyway, because pretending to certainty is how health content loses the right to be believed. The pattern by birth year points to something in early life that changed for people born after about 1950, and the suspects are the things that changed with them: diets built around ultra-processed food, more antibiotics in childhood, rising obesity, less movement, and shifts in the gut microbiome.

Microplastics are on the suspect list too. They have been found in human colon tissue, and animal studies show they can inflame the gut lining, but no study has yet linked a person's exposure to their cancer risk. It is a hypothesis under active investigation, not an answer.

Each of these suspects has evidence of association; none has been shown to explain the rise on its own, and plenty of young people diagnosed are fit, active people who eat carefully. These are hypotheses under active study, not established causes, and this article will not pretend otherwise. What matters for you is not why the curve is rising. It is what to do about the body you are living in while science argues.

The dismissal problem

Under screening age, which means under 50 in the UK and under 45 in the US, what you notice yourself is the only door into diagnosis. And what young people notice gets explained away, sometimes by doctors, very often by people themselves. Bleeding becomes haemorrhoids. A changed bowel habit becomes stress, or something you ate, or "probably IBS". Tiredness becomes life.

I want to be honest about my side of that paragraph, because I sit on the other side of the desk. Those explanations are usually right, and I reach for them myself. Most bleeding in a 30 year old genuinely is haemorrhoids. Most bloating genuinely is benign. The common explanations are common; that is exactly what makes this hard.

The failure is not the first, reasonable explanation. The failure is when that explanation ends the story instead of starting a safety net: no follow-up plan, no test, no "come back if this has not settled". That last sentence is the one I check myself for at the end of an appointment, because it is the difference between reassurance and a locked door.

The UK learned this story through one woman. Dame Deborah James, a journalist and former deputy headteacher, was diagnosed with bowel cancer in 2016, in her mid-thirties, fit and seemingly the wrong demographic entirely. She spent her remaining years making the country talk about poo, bodies and the cost of "too young", and when she died in 2022 at 40, the Bowelbabe Fund she founded with Cancer Research UK had raised millions for cancer research. If you are reading this in the US and do not know her name, that paragraph is her legacy working exactly as she intended.

Bowel Cancer UK has been documenting the same pattern for over a decade through its Never Too Young campaign. In its 2020 survey of more than 1,000 people diagnosed under 50, four in ten had seen their doctor three or more times about their symptoms before being referred for tests, and one in six had been six or more times. The charity's own figures put it plainly: one in four people diagnosed under 50 are diagnosed as an emergency, against one in seven of those over 50, and one in four under 50 are diagnosed at the latest stage, against one in five over 50. Later stage means harder roads and worse odds, for the group the system assumed was safe.

The rule change almost nobody has heard about

Quietly, the rules have already moved. In the UK, NICE guidance now recommends a FIT test, a simple home stool kit that detects tiny amounts of hidden blood, for an unexplained change in bowel habit in any adult, with no minimum duration. The criteria were rewritten in August 2023, and the age thresholds that used to govern this symptom went with them. Any adult. No waiting period. Your doctor can post you the kit.

I remember this change arriving as a routine guideline update, the kind of thing that crosses a doctor's desk without ceremony. It deserves more noise than it got, and making some is partly why this article exists.

In the US, the screening start age was lowered from 50 to 45 in 2021 by the US Preventive Services Task Force, precisely because of the early-onset rise. Below 45, what you notice still counts, and anyone with a strong family history of bowel cancer, or a known condition such as Lynch syndrome, should be having that conversation far earlier, in both countries.

How to be heard

If you are under 50 and worried, the appointment goes differently when you are direct, and I can tell you that from the other side of the desk. Say the actual words: "I am worried about bowel cancer." Doctors respond differently when the fear is named. I do. In the UK, ask the question the new guidance has already answered: "Could this be checked with a FIT test?"

Go in with specifics rather than a vague worry. None of these means cancer, and most of the time it will not be, but these are the ones worth naming out loud rather than waiting out:

  • Bleeding from the bottom, or blood in your stool, without an explanation a doctor has actually examined you for.
  • A change in your bowel habit, looser, harder, more often, less often, that has not settled. Or a change in the shape of your stool, particularly to thin, ribbon-like stools.
  • Losing weight without trying. That is never a lucky win to bank quietly.
  • Unexplained exhaustion, or a blood test showing anaemia.
  • Tummy pain that keeps coming back.
  • New lumps or bumps in your tummy that do not go away.
  • Relatives diagnosed with bowel cancer young. Mention it to your doctor, because it can run in families.

One skips the queue entirely: black, tarry stools, or a large amount of blood. That needs medical help the same day. Call 999 in the UK or 911 in the US if you also feel faint or are vomiting blood.

Ask what the plan is if things have not settled in a few weeks; a good answer includes when to come back. If a first visit did not resolve things and the change persists, go back; persistence is new information, not fussiness.

You are not being dramatic. Medicine's own data says the question is fair.

Screening is an excellent tool, but it is not perfect, and some people with cancer will have a negative screening test. In a Dutch study of nearly half a million people, FIT missed somewhere between one in ten and one in six of the bowel cancers that were there, depending on the threshold used. If you still think you are at risk, do not be afraid to ask about further testing, and our piece on what a colonoscopy actually involves explains what that step looks like.

Both things are true

Let me end with the balance a headline cannot hold, because holding it is most of my job. The absolute risk of bowel cancer in your 20s, 30s and 40s is still low, and most young people who notice the signs above will not have cancer. And the rise is real, the dismissal is documented, and the price of a wrong "you're too young" is measured in stages.

Both of these are true at once. The FIT test exists so that reassurance can be earned with evidence rather than assumed from a birthday.

Never too young is not a slogan. On the data in front of us, it is simply a description. I would rather you hear that from a doctor now than hear "you're too young" from one later.

Common questions

No age makes it impossible. Bowel cancer is still much more common after 50, and most young people who notice these signs will not have it, but rates under 50 have been rising for three decades and UK referral guidance no longer uses age as a reason not to investigate a change in bowel habit.

More from Digests.

Suna Digests explains how the gut works in plain, everyday terms, with the sources shown.

Sources

  1. 1Cancer statistics, 2024Siegel, Giaquinto & Jemal, CA: A Cancer Journal for Clinicians, 2024
  2. 2Colorectal cancer statistics, 2023Siegel, Wagle, Cercek, Smith & Jemal, CA: A Cancer Journal for Clinicians, 2023
  3. 3Colorectal cancer incidence patterns in the United States, 1974-2013Siegel, Fedewa, Anderson, Miller, Ma, Rosenberg & Jemal, Journal of the National Cancer Institute, 2017
  4. 4Colorectal cancer incidence trends in younger versus older adultsSung, Siegel, Laversanne et al., The Lancet Oncology, 2025
  5. 5Early-onset cancer: why are more young adults being diagnosed?Cancer Research UK, 2023
  6. 6Bowel cancer incidence statisticsCancer Research UK
  7. 7Never Too Young: tackling the challenges faced by people under 50 with bowel cancerBowel Cancer UK, 2020
  8. 8Suspected cancer: recognition and referral, NG12, recommendation 1.3.1National Institute for Health and Care Excellence, updated August 2023
  9. 9Quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care, HTG690 (formerly DG56)National Institute for Health and Care Excellence, 2023
  10. 10Screening for colorectal cancer: US Preventive Services Task Force recommendation statementUS Preventive Services Task Force, 2021
  11. 11Incidence of interval colorectal cancer after negative results from first-round faecal immunochemical screening testsToes-Zoutendijk et al., Clinical Gastroenterology and Hepatology, 2020
  12. 12Microplastic exposure and pathways of colorectal carcinogenesis: a systematic reviewAlbukhari, Journal of Toxicology, 2025
  13. 13Microplastics and the rising tide of early-onset colorectal cancerGosavi, Fong, Yap, Bell, Ooi & Narasimhan, ANZ Journal of Surgery, 2025
  14. 14NHS bowel cancer screeningNHS
Written by Dr Parisah Hussain, MBChB, BSc (Hons), DRCOG, MRCGP. Last updated . From Digests.

Words in this piece

Read next

All Digests

About Digests

Digests explains how the body works in general, everyday terms. It is not medical advice. It is not a substitute for someone who can examine you and knows your history, and we do not tell you what dose of any medicine to take.

Where we describe how something is checked or looked after, we follow UK guidance from NICE and the NHS, so the tests and routes where you live may differ. The same concerns are worth taking to your own doctor.

Some articles explain approaches that researchers have studied, including gut-directed hypnotherapy. Explaining an approach is education, not an offer of it: Suna does not provide hypnotherapy or any medical or psychological treatment.

Suna Health is building a wearable wellness device for gut health and offers a gut-directed relaxation app, and you will see both advertised alongside these pages. That commercial interest does not decide what the content says.

If you think we have got something wrong, tell us at digests@suna.health. It goes to the editor. Full terms, including our liability position, are at suna.health/terms.

The wearable for gut health and nutrition. Built by a passionate team, grounded in peer-reviewed research.

Suna

Suna is a wellness device, not a medical or diagnostic device. It does not diagnose, treat, cure, or prevent any disease. The Suna app offers a five-week gut-directed relaxation program for general wellbeing. The program is a self-guided wellness practice: it is not medical care, not psychological treatment, and not hypnotherapy, and it is not a substitute for care from a qualified practitioner. Information provided is general wellness information, not medical advice. Always consult a qualified healthcare professional about any health concern.

Suna Health US, Inc., 2810 N Church St STE 90849, Wilmington, DE 19802

© 2026 Suna Health.